Dominique Valteau-Couanet Selected Research

Dominique Valteau-Couanet Research Topics

Disease

58	Neuroblastoma 03/2024 - 10/2002
37	Neoplasms (Cancer) 02/2024 - 10/2002
12	Neoplasm Metastasis (Metastasis) 11/2023 - 07/2003
7	Medulloblastoma 11/2020 - 10/2005
4	Pain (Aches) 12/2018 - 12/2011
3	Sarcoma (Soft Tissue Sarcoma) 11/2023 - 06/2011
3	Second Primary Neoplasms (Neoplasms, Second) 11/2023 - 08/2017
3	Disease Progression 01/2021 - 07/2007
3	Infections 12/2018 - 07/2010
2	Glioma (Gliomas) 04/2022 - 06/2014
2	Residual Neoplasm 01/2019 - 10/2002
2	Fever (Fevers) 12/2018 - 07/2010
1	Drug-Related Side Effects and Adverse Reactions 03/2024
1	Heart Diseases (Heart Disease) 11/2023
1	Stroke (Strokes) 11/2023
1	Bone Diseases (Bone Disease) 11/2022
1	Ganglioneuroblastoma 11/2022
1	Proteinuria 04/2022
1	Epistaxis (Nosebleed) 04/2022
1	Hypertension (High Blood Pressure) 04/2022
1	Fatigue 04/2022
1	Neuralgia (Stump Neuralgia) 12/2019
1	Hepatoblastoma 01/2019
1	Pneumothorax 01/2019
1	Pulmonary Hypertension 12/2018
1	Hypersensitivity (Allergy) 12/2018
1	Hodgkin Disease (Hodgkin's Disease) 12/2018
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 12/2018
1	Heart Failure 12/2018
1	Lymphoma (Lymphomas) 12/2018
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2018
1	Mycoses (Diseases, Fungus) 12/2018
1	Capillary Leak Syndrome 12/2018
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 12/2018
1	Bone Marrow Diseases (Bone Marrow Disease) 01/2018
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2018
1	Seizures (Absence Seizure) 01/2018
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2018

Drug/Important Bio-Agent (IBA)

10	3-Iodobenzylguanidine (Iobenguane)IBA 11/2023 - 07/2003
7	dinutuximabIBA 03/2024 - 01/2018
7	Busulfan (Busulfex)FDA Link 10/2021 - 11/2012
6	Topotecan (Hycamtin)FDA LinkGeneric 01/2024 - 01/2017
6	Vincristine (Oncovin)FDA LinkGeneric 10/2021 - 01/2005
5	Interleukin-2 (IL2)IBA 10/2021 - 10/2002
5	Melphalan (Alkeran)FDA LinkGeneric 10/2021 - 06/2014
5	Etoposide (VP 16)FDA LinkGeneric 10/2021 - 01/2005
4	Temozolomide (Temodar)FDA LinkGeneric 03/2024 - 11/2006
4	AntibodiesIBA 03/2024 - 01/2018
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2021 - 01/2005
4	Carboplatin (JM8)FDA LinkGeneric 10/2021 - 07/2010
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 04/2014
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018 - 01/2005
3	Iodine-123IBA 11/2022 - 07/2003
3	Cisplatin (Platino)FDA LinkGeneric 10/2021 - 07/2010
3	DNA (Deoxyribonucleic Acid)IBA 10/2018 - 03/2009
3	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 01/2018 - 11/2012
3	Messenger RNA (mRNA)IBA 04/2014 - 10/2008
2	RNA (Ribonucleic Acid)IBA 02/2024 - 01/2018
2	Bevacizumab (Avastin)FDA Link 01/2024 - 04/2022
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2024 - 04/2022
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2021 - 11/2015
2	Morphine (MS Contin)FDA LinkGeneric 10/2018 - 01/2018
2	Cell-Free Nucleic AcidsIBA 01/2018 - 11/2016
2	LigandsIBA 01/2016 - 06/2011
2	Anaplastic Lymphoma KinaseIBA 01/2016 - 10/2008
2	Protein Isoforms (Isoforms)IBA 04/2015 - 06/2011
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 07/2010 - 10/2002
1	Angiogenesis InhibitorsIBA 01/2024
1	Isotretinoin (Accutane)FDA LinkGeneric 10/2021
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021
1	Biological FactorsIBA 01/2021
1	GangliosidesIBA 12/2019
1	Immune Checkpoint InhibitorsIBA 12/2018
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 12/2018
1	Monoclonal AntibodiesIBA 12/2018
1	Rituximab (Mabthera)FDA Link 12/2018
1	blinatumomabIBA 12/2018
1	Clonazepam (Rivotril)FDA LinkGeneric 01/2018
1	NivolumabIBA 01/2018
1	IodineIBA 01/2018
1	NucleotidesIBA 01/2018
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2018
1	CytokinesIBA 01/2018

Therapy/Procedure

31	Drug Therapy (Chemotherapy) 03/2024 - 09/2004
16	Therapeutics 02/2024 - 07/2003
16	Radiotherapy 11/2023 - 04/2010
13	Immunotherapy 03/2024 - 10/2002
8	Stem Cell Transplantation 01/2021 - 10/2002
4	Induction Chemotherapy 11/2023 - 01/2005
4	Neoadjuvant Therapy 11/2020 - 03/2014
3	Investigational Therapies (Experimental Therapy) 02/2024 - 01/2017
2	Aftercare (After-Treatment) 12/2018 - 11/2014
1	Off-Label Use 03/2024
1	Combined Modality Therapy 11/2023
1	Operative Surgical Procedures 01/2022
1	Palliative Care (Palliative Therapy) 12/2019
1	Metastasectomy 01/2019
1	Chest Tubes (Chest Tube) 01/2019
1	Radiofrequency Ablation 01/2019
1	Premedication 01/2018